PA
Paxman AB (publ)
PAX.ST · STO
59.70 kr -0.17% (-0.10 kr)
1M +29.36%
Market Cap 1.39B kr
P/E Ratio -
Div. Yield -
ROE 1.22%
Bulios Fair Price
30 kr
49.7% downside
Trenutna cena
59.7 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PAX.ST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
24 /100
Expensive EV/EBITDA 34.15x
P/B 3.33x
P/S 3.80x
Growth
100 /100
Growing Rev. growth 25.97%
Book val. growth 52.52%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 31.92%
FCF margin 6.60%
Net margin 1.38%
Quality
9 /100
Poor ROIC 1.20%
Asset turnover 0.75x
ROE 1.22%
Debt
88 /100
Low Debt/Equity 0.03x
Net debt/EBITDA -2.46x
Current ratio 4.39x
Stability
48 /100
Moderate Beta 0.48x
Profitable years 0
Rev. volatility 7.09%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PAX.ST
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Richard Paxman
Employees
151
Headquarters
Karlshamn
Prihajajoči dogodki
20 NOV.
Earnings
Upcoming earnings report